Life
SciencesThe health and life sciences sector
is worth £90bn to the UK’s economy,
one of the most productive in the world,
currently providing 282,000 jobs
and is growing.
Stanhope and its partners have invested
in providing real estate solutions for thisgrowing sector since 2014 with assets in
London, Oxford and Cambridge.

ID Manchester

Stanhope's
Life Sciences
Portfolio

Cambridge Science Park

Stanhope has assembled life sciencedevelopments across the Golden Triangle.
In London within three of the recognised
knowledge clusters: The British Libraryextension at the heart of The Knowledge
Quarter, at White City Place in the White City
Innovation District and at Royal Street in
SC1. Outside London at Oxford North and at
Cambridge Science Park.
We are also working with Bruntwood SciTech
and the University of Manchester on a newnorthern innovation district at ID Manchester.

Oxford North

White City PlaceRoyal Street

The British Library Extension

White City
Place
White City Place comprises a cluster of workspacebuildings united by new public realm and street level
retail, restaurants and cafés. It is occupied with a diverse
community of businesses.

New public realm at White City Place

The project included the refurbishment andrepositioning of 3 existing buildings to transformthem into modern working environments:
WestWorks, MediaWorks and the Garden House.
The buildings are ex BBC spaces and benefited
from a robust structure, generous floor to ceilingheights and riser space, which has enabled themto incorporate laboratory uses.

WestWorks building

Synthace laboratory, White City Place

As a result we have attracted 8 life science
occupiers, the majority of which are young
companies plus Novartis. These include
Autolus, Gamma Delta, Vivan Therapeutics,
Adaptate Therapeutics, Engitix, Synthace andour most recent, invoX.
White City Place has a mix of occupiers
including Huckletree (co-working), ITV,
JellycatLondon, Arts Alliance Media and theRoyal College of Art.

NOVARTI S

VIVAN TH E RAP E UTICS

The Basel-based pharmaceuticals giant
Novartis, specialising in innovative medicines,
cost-saving pharmaceuticals and eye care, has
moved its UK headquarters to 53,000 sq ft at
White City Place.

This London based biotechnology company
offers cancer patients access to the mostadvanced personalised cancer therapeutics
based on technology pioneered at The Mount
Sinai School of Medicine, New York. They
currently occupy 1,350 sq ft at White City Place.

SYNTHACE

This young biotech based in 13,000 sq ft at
White City Place is building Antha, a powerfulsoftware platform that “gives biologists
sophisticated, flexible and integrated control
over lab hardware.”

ADAPTATE B IOTH E RAP E UTICS

formerly Adaptate

AUTOLUSA biopharmaceutical company developing nextgeneration, programmed T cell therapies forcancer treatment. Autolus, which was valued at
US$534m as of summer 2018 occupies 33,000
sq ft at White City Place.

E NG ITI X

Engitix was created in 2016 to commercialise
cutting-edge ECM research at the Institute forLiver and Digestive Health, Division of Medicine,
University College London (UCL) and is now
a growing biotechnology company with over
30 employees.

An immunotherapy company developing an
innovative portfolio of therapeutic antibodies
designed to modulate the activity of a patient’s
own cytotoxic gamma delta T cells in situ. They
occupy over 2,000 sq ft at White City Place.
Adaptate was acquired by major global pharmacompany Takeda on 10 January 2022.

GAM MADE LTA

formerly GammaDelta

GammaDelta Therapeutics specialises indeveloping improved immunotherapies forthe treatment of cancer and other diseases.
It moved from the King’s Cross area into a new
12,000 sq ft office and lab at White City Place.
GammaDelta was acquired by major global
pharma company Takeda on 10 January 2022.

I NVOX

invoX Pharma Ltd (invoX) is a wholly-owned
subsidiary of Sino Biopharmaceutical Limited,a global top 50 pharmaceutical company.
Their mission is to become a fully integrated
biopharmaceutical company with an advancing
pipeline of innovative products addressing
unmet healthcare needs, worldwide.

White City
Place:
Gateway

Gateway East will be 21 storeys and will front
the newly created Arrival Square and Wood
Lane. The building will provide 607,763 sq ft
on the upper floors and the ground floor will
provide 20,947 sq ft of complementary retailand restaurant floor space.
Gateway Central provides 360,000 sq ft withcafes and restaurants at ground level andvaries in height from four to 12 storeys.
Gateway West site is a low-rise three and four
storey employment building of 30,000 sq ft.
Gateway East

Gateway is part of the White City Placedevelopment and will consist of threecommercial buildings.
Gateway West and Gateway Central haverecently completed, with global cosmetics
giant L'Oréal moving their HQ to a bespoke
240,000 sq ft building.
Gateway East is designed to be lab enabled.

Gateway West & Central with site of Gateway East in the foregroundEstate Life at
White City PlaceTH E P OD

The Pod is the Estate’s unique standalone
recording studio. Complete with professionalgrade equipment and a team of audio engineers,
the campus offers this recording facility to
podcasters, brands and storytellers. The
Estate’s own podcast series, Thought Starters,
is recorded in the Pod and connects
thought leaders for conversations about
the creative industry.

Our experience of creating mixed use developments,
often phased over several years, has equipped us withasset management skills which we apply at both themasterplan/design stage of new projects, and during
delivery and occupation. We are currently asset
managers for our White City developments.

In putting people at the heart of ourplaces, we focus on delivering places
that are innovative, fun and engaging.
Our ambition is to deliver distinctive andenduring places and spaces each capableof extraordinary experiences.

“White City is quickly becoming
one of the UK’s life sciences andtechnology districts.”
HAS E E B AH MAD, P R E S I DE NT, E U ROP E, NOVARTI S

At White City Place occupiers can enjoy
a wealth of food and drink, fitness andcultural amenities without leaving the
Estate. The attractive central avenue
and its expansive green spaces has
housed summer summer screenings,
classes, therapeutics, live music, pop-up
art installations and craft markets.
The Estate is championing campus
talent by providing a canvas for young
artists and space for up-and-coming
musicians. As well as demonstrating thesite’s dedication to nurturing culture,these public art pieces boost wellbeing
by providing a generous dash of colourfor occupiers out on a tea break.
Summer sports screenings

The Helix installation

Camille Walala’s major new work: a vivid installationin the artist’s signature geometric patterns over a sectionof the ground and The WestWorks building

BritishLibrary
Stanhope and Mitsui
Fudosan UK are working
with the British Library
to create an exciting
contribution to London’sKnowledge Quarter.
Bringing forward the development of a 2.8 acresite to the north of the British Library’s existing
Grade I Listed building. The site is immediately
south of the Francis Crick Institute, the largest
biomedical research facility in Europe.
The development will create an additional
100,000 sq ft of new space for the British Library
for learning, exhibitions and public use, including
a new northern entrance and a bespoke
headquarters for the Alan Turing Institute,the national centre for data science research.
In addition, the development will provide
new commercial space of c. 600,000 sq ft
for organisations and companies that wish
to be located at the heart of London’sKnowledge Quarter.
Resolution to grant planning was secured in
January 2023.

B R ITI S H LI B RARYThe British Library is the national library of
the United Kingdom and gives access to theworld’s most comprehensive research collection.
It provides information services to academic,
business, research and scientific communities.

ALAN TU R I NG I N STITUTE

The Alan Turing Institute, headquartered in the
British Library, was created in 2015 and is thenational institute for data science and artificial
intelligence. The British Library extension will
provide further space for the ATI’s expansion.

F RANCI S CR ICK I N STITUTE

Located immediately to the north of the British
Library, the Francis Crick Institute is Europe’s
largest bio-medical research institute, bringing
together 1500 scientists with founding partners
comprising the Medical Research Centre,
Cancer Research UK, Wellcome, UCL, Imperial
College London and Kings College London.

K NOW LE D G E QUARTE R

Made up of over 100 academic, cultural,
research, scientific and media organisations,large and small: from the British Library, Google
and the Wellcome Trust to Arts Catalyst,
Scriberia and the Wiener Library.

“We believe the Library expansion
brings with it the opportunity to see
meaningful and lasting changes that will
be beneficial to the whole community.”
N E E LAM PATE L, CEO, M E D CIT Y

RoyalStreetSt Thomas’ Hospital is one of the major
academic research centres and education
providers in England as part of King’s HealthPartners (KHP). KHP is one of 8 UK Academic
Health Sciences Centres alongside Imperial,
UCL, Oxford and Cambridge.

Stanhope and Baupost are developer partners
with Guy’s and St Thomas’ Foundation tobring forward a development on a 5.5 acre site
opposite St Thomas’ Hospital and close to
Waterloo Station.
Royal Street offers the potential to provide
a MedTech cluster of companies, academic
researchers and clinicians creating a newcommercial neighbourhood in central London,
which will become an integral and hugely
beneficial part of the existing local community.

Royal Street’s USP is its location next to
St Thomas’ Hospital, with its world leading
medical and research facilities, supported byKing’s College. King’s leading Faculty of Life
Sciences & Medicine comprises more than
2,000 staff and 5,000 students across four
London campuses. This co-location of medical
and academia, reinforced by excellent transport
connectivity, make it an ideal location for a
MedTech cluster.
Project Status: Resolution to grant planning was
secured in December 2022.

G UY’S & ST THOMAS’N H S FOU N DATION TR UST

As part of King’s Health Partners, an academic
health sciences centre, Guy’s & St Thomas’
NHS Foundation Trust are pioneers in healthresearch, and provide high quality teachingand education. This partnership helps themprovide the latest treatments alongside the best
possible care. The Trust plan to take space inthe development.

Creating a home for a thriving
science and technology community.
In 2022, together with Cadillac Fairview, we were selected
as partners to Thomas White Oxford Limited, the property
development subsidiary of St John's College Oxford.
The vision for Oxford North is to become a new urban district
within Oxford which will facilitate science and technology
discoveries. A place where people want to live, work, visit andlearn. Somewhere which benefits everyone and delivers realsocial value; ensuring it connects and enhances the local areawith open spaces, public art, events and culture.
Oxford North comprises approximately 1 million sq ft oflaboratories, workspace, retail and amenities. It is being
designed by a world class team of masterplanners, architects,
engineers and specialist consultants.
The project is anticipated to boost the economy by circa £150
million in GVA per annum, and to provide over 4000 jobs on site.
Enabling works are underway and Phase 1 buildings are tocommence on site in 2023.

OxfordNorth

Stanhope and Cadillac Fairview cement
their long-term commitment to the UK
life sciences market, with four properties
within Cambridge Science Park.
Established nearly 50 years ago, Cambridge Science Park is a globallyrenowned centre of excellence within the science and innovation Sector.
Plot 194-198
The three-building campus is set across 6.11 acres. Working closelywith the three existing tenants, Microsoft, Mundipharma (NappPharmaceutical) and CMR Surgical, the site also provides significant
longer-term development opportunities.
Plot 163
This site occupies a prominent location on the eastern side of the parkand provides 10,197 sq ft of office space. It is currently occupied by
speciality lighting company, Heraeus Noblelight Ltd and represents anear-term opportunity to develop prime life sciences lab space at the park.

Cambridge
Science Park

ID
ManchesterN

Stanhope is supporting thejoint venture partnership
between Bruntwood SciTech
and the University ofManchester to develop ID
Manchester. Based in theheart of the city of Manchesterand set over 9 hectares.
ID Manchester will be a new kind of place an innovation platform, home to the most
exciting new ideas and ventures, addressing
some of humanity's greatest challenges andopportunities.
The University of Manchester is on a
mission to become the innovation capital of
Europe. Building on its world-class research,extensive business network and strong civic
relationships, the University is powering theinnovation ecosystems that flow across Greater
Manchester and beyond.
ID Manchester will be key to realising this goal. A
new, world-class innovation district situated in
one of the world’s greatest cities, neighbouring
the University and building upon its proudhistory of bold ideas, discovery and invention.
ID Manchester will provide a new community forforward-thinking, like-minded individuals andbusinesses. A place where they can start or scale
their UK HQ.

Innovation will be fostered through spaces
designed to collide, collaborate and create.
ID Manchester will be a highly connected newcity neighbourhood in an unrivalled City Centre
location. It sits adjacent to Manchester’s main
public transport hub, Piccadilly Railway Station,is 20 minutes by train to the international
airport and, once HS2 is completed, will bejust over one hour from London by train andthe most connected location in the North ofEngland.
Setting a new standard for urban regeneration atscale, it plans to create 10,000 high-quality new
permanent jobs, 2.6m sq ft of new workspace,
two hotels and 1,350 new homes. ID Manchester
will also invest over £28 million in its public
realm to create a canvas for its vibrant culturaland events programme, enlivening this new areaof the City for residents and visitors alike.

Our
Expertise

Stanhope undertakes all of its projects in partnershipwith landowners, investors, occupiers and industry
colleagues. We have delivered developments with over
90 partnerships to date, current partners include:

Stanhope has over 25 years’ experience ofdelivering a broad and complex range of projects.

8
life science projects

c.3m
sq ft under construction/in preparation

131k sq ft
of life science occupiers

£30bn

C-01

清刷・三菱地所グループ及び三菱地所ロゴタイプ

Reproduction Data

三菱地所グループロゴタイプ（和文）

三菱地所グループロゴタイプ（英文）三菱地所ロゴタイプ（和文略称社名）

三菱地所ロゴタイプ（英文略称社名）

三菱地所ロゴタイプ（和文正式社名）

三菱地所ロゴタイプ（英文正式社名）

of real estate value delivered
and under construction

9.5m

100+

sq ft development pipelineAwards received
31

Stanhope’s in-houseteam comprises
development management
and construction experts:
financiers, surveyors,planners, engineers,architects, marketeers
and asset managers.

Joe Binns
H EAD OF N EW B US I N E S SDavid CampCharles Walford

David ReayCEOS E N IOR DEVE LOP M E NT DI R ECTORAN D H EAD OF LI F E SCI E NCE S

DEVE LOP M E NT DI R ECTOR

Kevin Darvishi

Paul March

Elie Rigg

LEAS I NG DI R ECTORP ROJ ECT DI R ECTORP ROP E RT Y E X ECUTIVETE R M S & CON DITION S
Copyright© Stanhope PLC 2023
All rights reserved.

By attending this presentation and/or receiving this

These obligations shall not apply to:

document, you, the recipient, are agreeing to the terms andinformation which at the time of disclosure is in the publicconditions set forth below.

domain; or

THIS DOCUMENT IS CONFIDENTIAL AND IS BEING

information which, after its disclosure, enters the public

PROVIDED TO YOU SOLELY FOR YOUR INFORMATION

domain by lawful and proper publication; orAND, IF APPLICABLE, YOUR EVALUATION AS PART

information which the recipient can establish by reasonable

OF A BID OR TENDER PROCESS AND MAY NOT BE

proof was in the recipient’s possession at the date of this

REPRODUCED OR REDISTRIBUTED (IN WHOLE OR IN

document or was subsequently and independently developed;

PART) TO ANY OTHER PERSON OR FOR ANY OTHERorPURPOSE.
information which the recipient is required by law to disclose.
This document, its contents and any other related

These obligations shall continue without limitation in point of

information provided to you are confidential and must not betime until the information enters the public domain without

released, published, distributed, reproduced or redistributed

fault on the recipient’s part.

(in whole or in part) by any medium or in any form by therecipient in or into any jurisdiction (including but not limited

None of Stanhope plc or any of their respective shareholders,

to the United Kingdom), or be disclosed or made available bydirectors, employees or agents or any other person shallthe recipient to any other person. The recipient must treat

have any liability whatsoever (in negligence or otherwise)

and safeguard as private and confidential all information

for any loss however arising from any use of this document

contained in this document and take all reasonable steps toor its contents or otherwise arising in connection with thispreserve such confidentiality. No part of this document may

presentation.

be reproduced, stored in a retrieval system or transmitted or
copied in any form or by any means, electronic, mechanical,
photocopying or recording otherwise, without the priorwritten permission of Stanhope plc.

Stanhope Plc
2nd Floor
100 New Oxford Street
London WC1A 1HB
Tel: +44 (0)20 7170 1700
Registered in England No. 3017841
VAT Registration No. 305 6256 20

One Mabledon Place was Stanhope's first life
science project. The building was prelet in2014 to The Doctors Laboratory - the largest
independent provider of clinical laboratory
diagnostic services in the UK.

STAN HOP E P LC.C OM